EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study

Deborah Katharina Erhart iD, Veronika Klose iD, Tatjana Schäper, Hayrettin Tumani iD, Makbule Senel iD

International Journal of Molecular Sciences · 28.12.2023 · 25 (1) · 425

DOI: 10.3390/ijms25010425 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.12.2023. Verfasst von Deborah Katharina Erhart und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany. Hauptthemen laut MEDLINE: Multiple Sclerosis, Neurosyphilis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

C-X-C-motif chemokine ligand 13 (CXCL13) in cerebrospinal fluid (CSF) is increasingly used in clinical routines, although its diagnostic specificity and divergent cut-off values have been defined so far mainly for neuroborreliosis. Our aim was to evaluate the value of CSF-CXCL13 as a diagnostic and treatment response marker and its role as an activity marker in a larger disease spectrum, including neuroborreliosis and other neuroinflammatory and malignant CNS-disorders. Patients who received a diagnostic lumbar puncture (LP) (n = 1234) between July 2009 and January 2023 were included in our retrospective cross-sectional study. The diagnostic performance of CSF-CXCL13 for acute neuroborreliosis was highest at a cut-off of 428.92 pg/mL (sensitivity: 92.1%; specificity: 96.5%). In addition, CXCL13 levels in CSF were significantly elevated in multiple sclerosis with clinical (p = 0.001) and radiographic disease activity (p < 0.001). The clinical utility of CSF-CXCL13 appears to be multifaceted. CSF-CXCL13 is significantly elevated in patients with neuroborreliosis and shows a rapid and sharp decline with antibiotic therapy, but it is not specific for this disease and is also highly elevated in less common subacute neuroinfectious diseases, such as neurosyphilis and cryptococcal meningitis or in primary/secondary B-cell lymphoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisNeurosyphilisHumansCross-Sectional StudiesRetrospective StudiesSpinal PunctureSyndromeChemokine CXCL13

Stichwörter der Autor:innen

CNS-inflammatory diseasesCXCL13cerebrospinal fluidneuroborreliosis

Substanzen

CXCL13 protein, humanChemokine CXCL13

Autor:innen und Institutionen

  • Department of Neurology, University Hospital of Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.
  • German Center for Neurodegenerative Diseases (DZNE)-Ulm, Oberer Eselsberg 45, 89081 Ulm, Germany.

ORCID-Profile: Deborah Katharina Erhart, Veronika Klose, Hayrettin Tumani, Makbule Senel

Zitieren

APA

Erhart, D. K., Klose, V., Schäper, T., Tumani, H., & Senel, M. (2023). CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study. International Journal of Molecular Sciences, 25(1), 425. https://doi.org/10.3390/ijms25010425

Vancouver

Erhart DK, Klose V, Schäper T, Tumani H, Senel M. CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study. International Journal of Molecular Sciences. 2023;25(1):425. doi:10.3390/ijms25010425

BibTeX
@article{Erhart2023,
  author = {Erhart, Deborah Katharina and Klose, Veronika and Schäper, Tatjana and Tumani, Hayrettin and Senel, Makbule},
  title = {CXCL13 in Cerebrospinal Fluid: Clinical Value in a Large Cross-Sectional Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {25},
  number = {1},
  pages = {425},
  doi = {10.3390/ijms25010425}
}
Kostenlos starten →